Alector, Inc.
Support and Resistance Levels
Past performance
News About ALEC
All events for ALEC
All deals for ALEC
Financial Ratios
Financial Statements
ALEC vs Sector & Peers
About Alector, Inc.
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA. Website alector.com
Headquarters South San Francisco, CA, US